Long-term outcome of etanercept therapy in children with treatment-refractory uveitis.
Reiff
Andreas
A
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002648:Child; D002908:Chronic Disease; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D011446:Prospective Studies; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D014605:Uveitis / Q000188:drug therapy*
D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept